New shot for gout flashes? early trial tests LEO 158968

NCT ID NCT06444867

Completed Symptom relief Sponsor: LEO Pharma Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early study tested a single injection of a new drug, LEO 158968, in 6 people having a gout flare. The goal was to see if it could reduce joint pain. The trial is complete, but results are not yet public.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: LEO 158968
What this could lead to: If it works, this could point toward a new option for quickly relieving gout flare pain.
What could go wrong: This is a very early, tiny trial with only 6 people. Results may not apply to everyone, and the drug may not work or could have side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GOUT FLARES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Arthralgia arthritic joint disease gout

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GOUT FLARES JOINT INFLAMMATION JOINT PAIN

Contacts and locations

Locations

LEO Pharma Investigational Site

Lille, 59400, France
LEO Pharma Investigational Site

Venlo, 5912 BL, Netherlands
LEO Pharma Investigational Site

London, EC2Y 8EA, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.